Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03893708
Other study ID # STUDY00007808
Secondary ID FP00012624
Status Completed
Phase N/A
First received
Last updated
Start date June 12, 2018
Est. completion date December 1, 2019

Study information

Verified date January 2021
Source Arizona State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test the feasibility (i.e., acceptability, demand) of a 12-week prenatal yoga intervention on excessive gestational weight gain (GWG) in pregnant women in the second trimester (enrolled at 12-24 weeks). Participants will be randomized into the prenatal yoga intervention or a pregnancy education (e.g., information on preparing for motherhood, labor and delivery etc.) control group. Participants in both groups will be asked to attend one 75 minute class per week. The investigators hypothesize that prenatal yoga intervention will be feasible for pregnant women. The study aims are as follows: Primary Aim: Determine the feasibility (i.e., acceptability, demand) of a 12-week prenatal yoga intervention in pregnant women. In a randomized controlled pilot study comparing prenatal yoga to a pregnancy education control condition, the investigators will assess 1) acceptability (defined as satisfaction, intent to continue use, perceived appropriateness) and 2) demand (defined as attendance/adherence). Exploratory Aim 1: Ascertain the preliminary effects of prenatal yoga on excessive GWG [i.e., weight gain exceeding Institute of Medicine (IOM) recommendations]. The investigators will compare weight change between intervention and control groups. Exploratory Aim 2: Explore the potential mediators (i.e., mindfulness, self-regulation) on the effect of prenatal yoga on excessive GWG.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date December 1, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 46 Years
Eligibility Inclusion Criteria: - Women 18-46 years of age (childbearing age) - Primiparous (women giving birth for the first time) - 12-24 weeks gestation at onset of intervention - Reside in the Phoenix Metropolitan area - Singleton pregnancy - English speaking - Not planning on moving before giving birth - Can attend at least one session per week Exclusion Criteria: - Current alcohol or substance abuse - Engage in =150 min of physical activity - Participation in =30 minutes/week of yoga or contemplative practice (i.e., meditation, qigong) for the previous six months - Pre-pregnancy BMI =40 or <18.5 - Denial of physical activity participation from a physician (PARmed-X for pregnancy)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Prenatal yoga
The prenatal yoga classes will be offered at Urban Wellness (2024 N. 7th St., Phoenix, AZ 85006). Classes will be offered Tuesdays's from 4:15-5:30 pm and Saturday's from 9:00-10:15 am. Participants will be able to attend both classes if they so choose but are only asked to attend 1/week. Participants will be asked to arrive to class at least 10 minutes early in order for the research team to collect their weight in a private room. Additionally, if participants have attended at least 70% of classes (1 per week for 8/12 weeks), participants will be able to attend sessions up until birth (beyond the 12-week intervention) if they so choose. If participants decide to attend classes beyond the 12-week intervention the investigators will continue to collect their weight at each session.
Pregnancy education
Pregnancy education classes will be offered at the Arizona Biomedical Collaborative Building on ASU Phoenix Campus. Classes will be offered on Tuesday's from 5:30-6:45 pm and Saturday's from 9:00-10:15 am. Participants will be able to attend both classes if they so choose but are only asked to attend 1/week. Participants will be asked to arrive to class at least 10 minutes early in order for the research team to collect their weight in a private room. Additionally, if participants have attended at least 70% of classes (1 per week for 8/12 weeks), participants will be able to attend sessions up until birth (beyond the 12-week intervention) if they so choose. If participants decide to attend classes beyond the 12-week intervention the investigators will continue to collect their weight at each session.

Locations

Country Name City State
United States Arizona Biomedical Collaborative (ASU) Phoenix Arizona
United States Urban Wellness Phoenix Arizona

Sponsors (2)

Lead Sponsor Collaborator
Arizona State University Kripalu Center for Yoga and Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acceptability via satisfaction survey at post-intervention Acceptability (defined as satisfaction, intent to continue use, perceived appropriateness); Benchmarks for acceptability include =70% of the sample will report the yoga intervention to be a satisfactory, useful, and appropriate modality to prevent excessive GWG. post-intervention (12-weeks)
Primary Demand (attendance/adherence) of yoga intervention Demand was measured using attendance/adherence to the yoga intervention. Attendance was tracked by a researcher who was present at each yoga session. Benchmarks for demand include =60% of participants in each group will attend one class per week. Weekly (during 12-week intervention)
Secondary Number of participants with excessive GWG (total GWG from baseline to delivery) Weight gain exceeding IOM recommendations Weekly (during 12-week intervention) and at delivery (up to 42 weeks gestation)
Secondary Mindfulness (mean change from baseline) Self-report mindfulness scores via Mindful Attention Awareness Scale (MAAS); 15-item questionnaire with score ranges 1-6. Higher scores reflect higher levels of dispositional mindfulness. Baseline, post-intervention (12-weeks)
Secondary Self-awareness (mean change from baseline) Self-report self-awareness scores via Self-Awareness Outcomes Questionnaire (SAOQ); Consists of 38 items measuring 4 subscales (reflective self-development, acceptance, proactive at work, and emotional costs). Score ranges for each subscale are between 1-5. Higher scores represent a greater frequency of experienced outcomes. Baseline, post-intervention (12-weeks)
Secondary Emotion Regulation (mean change from baseline) Self-report emotion regulation scores via Emotional Regulation Questionnaire (ERQ); Consists of 10 items measuring 2 subscales (reappraisal items, suppression items). Score ranges for each subscale are between 1-7. The higher the scores, the greater the use of the emotional regulation strategy. Baseline, post-intervention (12-weeks)
Secondary Sleep Quality (mean change from baseline) Self-report sleep quality via Pittsburgh Sleep Quality Index (PSQI); Consists of 10-items. In scoring the PSQI, seven component scores are derived ranging from 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. Baseline, post-intervention (12-weeks)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03249896 - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes N/A
Recruiting NCT04043520 - Bioenergetic Effects of Aging and Menopause (BEAM) Phase 4
Completed NCT05508750 - Growth and Safety Clinical Trial on a New Infant Formula N/A
Not yet recruiting NCT03225456 - Oxytocin and Eating Phase 2
Completed NCT02227043 - Study Of Weight Development Over Time N/A
Completed NCT01958307 - Healthy Living in Pregnancy N/A
Not yet recruiting NCT01916603 - Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development N/A
Completed NCT01693666 - Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study) N/A
Completed NCT01461824 - Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects Phase 3
Terminated NCT00759993 - Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units. Phase 2
Completed NCT00634530 - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy N/A
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00122213 - A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women Phase 2
Completed NCT00306449 - Prevention of Weight Gain in Young Adults N/A
Completed NCT03996551 - ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study N/A
Recruiting NCT03675464 - Study of Human Adipose Tissue (LOSHAT)
Completed NCT04282655 - Effect of Milk Warming on the Very Low Birth Weight Infant N/A
Recruiting NCT05992688 - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time) N/A
Completed NCT04069351 - Body Composition Changes During Overfeeding Plus Resistance Training N/A
Completed NCT00687115 - Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting Phase 2